Key findings

Postdiagnostic use of statins and metformin, but not low-dose aspirin, reduces the risk for breast cancer-specific death by 16%-30%, according to a Norwegian nationwide population-based cohort study appearing in Breast Cancer Research .

Background and/or implications

Biological mechanisms suggest breast cancer survival benefit from the three drugs under ...